Zhejiang Orient Gene Biotech Co., Ltd.
Shanghai Stock Exchange 688298.SS
Zhejiang Orient Gene Biotech Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2023: USD 734.82 M
-
Zhejiang Orient Gene Biotech Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2022 was USD 1.12 B, a 13.99% change year over year.
-
Zhejiang Orient Gene Biotech Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2021 was USD 986.18 M, a 187.68% change year over year.
-
Zhejiang Orient Gene Biotech Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2020 was USD 342.80 M, a 2,694.12% change year over year.
-
Zhejiang Orient Gene Biotech Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2019 was USD 12.27 M, a -17.72% change year over year.
| Date | Cash and Short-Term Investments | Receivables | Inventory | Goodwill |
|---|
| CEO | Mr. Xiaoliang Fang |
| IPO Date | Feb. 5, 2020 |
| Location | China |
| Headquarters | 3787#, East Yangguang Avenue |
| Employees | 2,231 |
| Sector | Health Care |
| Industries | |
Zhejiang Orient Gene Biotech Co., Ltd. researches and develops, produces, and sells colloidal gold tests, urinalysis strips, raw materials, instruments, and molecular diagnosis products primarily in China. Its products include genetic diagnosis products; colloidal gold rapid diagnostic tests for drugs of abuse, infectious diseases, fertility, cardiac and tumor markers, and autoimmunity; dry chemical strips; bio-liquid diagnostic kits; clinical test instruments; POCT time-resolved fluor immunoassay test kits; raw materials; etc. The company also exports its products to North and South America, Europe, South Asia, Southeast Asia, the Middle East, Africa, Russia, and Australia. Zhejiang Orient Gene Biotech Co., Ltd. was founded in 2005 and is based in Huzhou, China.
Past 5 years
USD 3.37
USD 0.79
USD 2.80
USD 9.57
StockViz Staff
January 15, 2025
Any question? Send us an email